Sanofi Forecasts Strong Flu Vaccine Growth, Accelerates COVID Plans
Two-Dose Coronavirus Vaccine Needed Even With Adjuvant
While Dupixent and oncology provide the backbone for future growth, Sanofi could seize an opportunity to expand its vaccines business greatly.
